The history of Sildenafil presents a challenging picture for those considering investment. While the initial launch generated significant returns, the end of its exclusive rights opened the door to cheaper alternatives, dramatically eroding market share. This presents a specific risk for drug manufacturers depending on comparable blockbuster medica

The legacy of Viagra, and its parent company copyright, presents a challenging case study for investors. Initially a blockbuster drug, yielding billions in sales , its exclusivity period created a flood of generic competition , significantly impacting its market share . While specific pharmaceutical companies may seek to capitalize on related treat